FIRST LINE CHEMOTHERAPY WITH PEMETREXED PLUS CISPLATIN IN ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A COMPARISON OF TWO PHASE III TRIALS

被引：0
|
作者：
Scagliotti, Giorgio [1 ]
Gridelli, Cesare
De Marinis, Filippo
Thomas, Michael [2 ]
Dedui, Mircea [3 ]
Pujol, Jean-Louis [4 ]
Manegold, Christian [5 ]
Melemed, Symantha [6 ]
John, William [6 ]
Zimmermann, Annamaria H. [6 ]
Chouaki, Nadia [7 ]
Melemed, Allen [6 ]
Visseren-Grul, Carla
Paz Ares, Luis [8 ]
机构：
[1] Univ Turin, Thorac Oncol Unit, I-10124 Turin, Italy
[2] Univ Heidelberg, Thoraxklin, D-6900 Heidelberg, Germany
[3] Inst Oncol, Bucharest, Romania
[4] Montpellier Acad Hosp, Montpellier, France
[5] Univ Heidelberg, Med Ctr, D-6900 Heidelberg, Germany
[6] Eli Lilly & Co, Indianapolis, IN USA
[7] Eli Lilly & Co, Suresnes, France
[8] Univ Hosp, Virgen Del Rocio, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Cisplatin; nonsquamous; first-line; Pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1160 / S1161
页数：2
相关论文
共 50 条
  • [1] THE BUDGETARY IMPACT OF PEMETREXED PLUS CISPLATIN AS FIRST-LINE THERAPY FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)
    Wielage, R. C.
    Muehlenbein, C. E.
    Liepa, A. M.
    Babineaux, S. M.
    Klein, R. W.
    Schwartzberg, L. S.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A39 - A39
  • [2] Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase III trials
    Treat, J.
    Scagliotti, G.
    Peng, G.
    Monberg, M. J.
    Obasaju, C. K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Pemetrexed-based chemotherapy in advanced nonsquamous non-small cell lung cancer (NSCLC).
    Alshehri, Abdulrahman Ali
    Alsubait, Saud Abdullrhman
    Alamgir, M. Ahsan
    Park, Chandler
    Wen, Sijin
    Luo, Jin
    Ma, Patrick
    Monga, Manish
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [4] COMPARISON OF PEMETREXED PLUS CISPLATIN WITH OTHER FIRST-LINE DOUBLETS IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A COMBINED ANALYSIS OF THREE PHASE 3 TRIALS
    Treat, Joseph
    Scagliotti, Giorgio
    Peng, Guangbin
    Pohl, Gerhardt
    Obasaju, Coleman
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S415 - S416
  • [5] Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials
    Treat, Joseph
    Scagliotti, Giorgio V.
    Peng, Guangbin
    Monberg, Matthew J.
    Obasaju, Coleman K.
    Socinski, Mark A.
    [J]. LUNG CANCER, 2012, 76 (02) : 222 - 227
  • [6] First-line cisplatin plus pemetrexed therapy for selected patients with advanced nonsquamous non-small cell lung cancer.
    Nakashima, Kazuhisa
    Murakami, Haruyasu
    Imai, Hisao
    Ono, Akira
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Endo, Masahiro
    Takahashi, Toshiaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Cost-Effectiveness of Pemetrexed Plus Cisplatin as First-Line Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer
    Klein, Robert
    Muehlenbein, Catherine
    Liepa, Astra M.
    Babineaux, Steve
    Wielage, Ron
    Schwartzberg, Lee
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (11) : 1404 - 1414
  • [8] EFFECTIVENESS OF FIRST-LINE PEMETREXED PLUS PLATINUM FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Brandao, M. D. R. A.
    Luis, M. S.
    Amaral, N. C.
    Cassiano Neves, M.
    Camacho, C.
    Rodrigues, A. C.
    Pousa, I.
    Oliveira, J.
    Azevedo, I.
    [J]. ANNALS OF ONCOLOGY, 2015, 26
  • [9] Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials
    Scagliotti, G. V.
    Gridelli, C.
    de Marinis, F.
    Thomas, M.
    Dediu, M.
    Pujol, J. -L.
    Manegold, C.
    San Antonio, B.
    Peterson, P. M.
    John, W.
    Chouaki, N.
    Visseren-Grul, C.
    Paz-Ares, L. G.
    [J]. LUNG CANCER, 2014, 85 (03) : 408 - 414
  • [10] A phase II trial of first-line bevacizumab in combination with pemetrexed and carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC)
    Skaff, Z. G.
    Hageboutros, A.
    Krieger, K.
    Coakley, S.
    Somer, R.
    Stevenson, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345